Appropriate Sampling of Lumpectomy Specimens

Slides:



Advertisements
Similar presentations
Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Surgical Pathology of Wide Local Excision of Breast
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08.
In The Nam of God.
AJCC TNM Staging 7th Edition Breast Case #3
What to Expect When a Lump Is Detected
Breast Imaging Made Brief and Simple
Tissue Sampling Options Lisa A. Newman, M.D., M.P.H., F.A.C.S. Professor of Surgery Director, Breast Care Center University of Michigan Ann Arbor, MI.
In The Nam of God.
Ductal Carcinoma in situ
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
BI-RADS By Nina Zahedi MD.
Tumor Localization Techniques Richard Kao April 10, 2001 Computer Integrated Surgery II.
How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.
Marion C.W. Henry, MD Yale University
The Value of Six Month Interval Imaging Following Benign Radiologic-Pathologic Concordant Minimally Invasive Breast Biopsy Manjoros DT, Collett AE, Alberty-Oller.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
WORK UPS. Ultrasound method of choice for the differentiation of cysts from solid masses and for guidance in interventional procedures. Benign: – solid.
What’s Next After an Abnormal Screening Mammogram? James A Stewart M.D. Elizabeth Burnside M.D.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
The Breast Clinic Index case Year 2 Michaelmas term.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Introduction to Breast Imaging BREAST RAD LAB Directions: Please answer all the questions prior to interactive conference. 1.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Histology Techniques CLS 322
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
INTERVENTIONAL LOCALIZATIONS Needle Localizations Parallel Approach/Surgical Approach AP Approach/Surgical Approach How Lesions Move Set-up/Procedure.
Pathology.
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
Radiological-histological size correlation in triple-negative breast cancer (TNBC) Abstract # 8254 C Thibault 1, M Gosset 2, F Chamming’s 3, M-A Lefrere-Belda.
J Clin Endocrinol Metab, Sep 2006, 91(9):
Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement Radiology 2005; 237: Presented.
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
Ultrasound breast core needle biopsy
Indications for Breast MR Imaging
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Mammograms and Breast Exams: When to start /stop mammograms
Sonography of the Breast Part III Lecture 12 Invasive Procedures
 [P1]Can you put in the numbers here for specificity and NPV
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Surgical Cancer Treatment
Erica V. Bloomquist, MD Heather Wright, MD
5A 5B 1A 1B 4A 4B Radiological Differences Between
SPECIMEN SONOGRAM - Procedure
Breast Imaging Ravi Adhikary, MD.
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Beyond Mammography: New Frontiers in Breast Cancer Screening
Current Status of Breast Ultrasound
Jeong Mi Park, MD, Limin Yang, MD, PhD, Archana Laroia, MD, Edmund A
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Avoiding Pitfalls in Mammographic Interpretation
Treatment Overview: The Multidisciplinary Team
Jeong Mi Park, MD, Limin Yang, MD, PhD, Archana Laroia, MD, Edmund A
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Which Way is Up? Policies and Procedures for Surgeons and Pathologists Regarding Resection Specimens of Thymic Malignancy  Frank C. Detterbeck, MD, Cesar.
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
ULTRASOUND NEWS
Figure 1. Radiographic and gross pathologic measurements of ‘tumor mass’ include areas of immune-mediated tumor ... Figure 1. Radiographic and gross pathologic.
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Marion C.W. Henry, MD Yale University
New Provider and Reappointment Training
Presentation transcript:

Appropriate Sampling of Lumpectomy Specimens Carol L. Schiller, M.D. Midwest Diagnostic Pathology, Advocate Condell Medical Center July 20, 2010

Why Do Breast People Want to Put Through So Many Darn Sections? Carol L. Schiller, M.D. Midwest Diagnostic Pathology, Advocate Condell Medical Center July 20, 2010

Appropriate Sampling of Lumpectomy Specimens Carol L. Schiller, M.D. Midwest Diagnostic Pathology, Advocate Condell Medical Center July 20, 2010

Objectives Outline available recommendations (though notably limited), expectations of “breast community” for optimal processing of lumpectomy (less than total mastectomy) specimens Sampling: How much? Why? Discuss at least a rough standard framework / protocol amongst sites Provide adequate and appropriate information for patient management decisions Foster optimal resident teaching Try to explain why breast people want to put through so many sections

Some things should be easy to agree on (right?) Know history Orient Weigh Measure in three dimensions Ink Slice Describe Sample (ahhh, here comes the conflict)

Before You Cut… Know history Palpable mass Mammographic findings Distortion Calcifications Size/extent/additional imaging modalities (MRI) Prior biopsy findings (date, multiple) If biopsy more than three months ago, is this post-neoadjuvant?

Before You Cut… Orientation Specimen imaging Per CAP: “Mammography or ultrasound should be used to document the presence of the targeted lesion in the excised tissue” “The specimen radiograph (if performed) and the results of the radiologic evaluation should be available to the pathologist.” Unoriented needle loc’s: Can’t assume orientation based on needle or grid Surgeon orientation must include two perpendicular references to be of value If surgeon attempted to orient but it doesn’t make sense to you, call immediately

Before You Cut… Weigh Measure in three dimensions Ink If specimen is oriented, measurements should be oriented Ink Area indicated on mammography grid Inking may roughly help direct sampling (only indicates the tissue slices, not the blocks likely to contain mammographic area of interest) Make sure doesn’t interfere with clear delineation of the six sides of the specimen

Before You Cut… Ink: Six colors vs. four colors Advantage of six: Same every time, avoids confusion Four: Variable, changes with orientation/direction of slicing If six, best to have a standard Superior = blue (sky) Inferior = green (grass) Lateral = yellow (l’s) Medial = red (med rhymes with red) Deep = black (dirt is deeper than grass) Anterior/Superficial = orange (it’s what’s left)

Get Cutting Slice and lay out sequentially Describe Sample Mass, measurements Biopsy site(s), presence/shape of clip(s)/clip housing material, tissue slice from which clip recovered Percentage of fatty vs. fibroglandular (“white”) breast tissue Measurment of gross distance to at least closest margins Sample

Sampling Published guidelines very limited Commercial grossing manuals Individual grossing protocols/Anecdotal practices from larger breast centers, cancer centers Guidelines from professional organizations (pathology, multidisciplinary) Differ based on targeted lesion Palpable mass Image detected mass/distortion Image detected calcifications

Image Detected Lesions (Ca++) Lester, Susan C (Manual of Surgical Pathology, 2nd ed): Entirely submit if can fit in 20 blocks or less; If entire specimen not submitted, include statement estimating %age of specimen submitted High suspicion or prior dx of DCIS or ADH on core: Completely submit all tissue containing mammographic calcifications and adjacent tissue All fibrous tissue (if feasible) At least two perpendicular sections of each of 6 margins

Image Detected Lesions (Ca++) Lester (cont.) Low suspicion lesion: Completely submit all tissue containing calcifications Adjacent tissue on either side 2 perpendicular sections of each 6 margins Keep remaining slices in order/maintain orientation; If blocks of calcifications have ADH or DCIS, all additional fibrous tissue should be examined microscopically

Image Detected Lesions (Ca++) Rosai (Rosai and Ackerman’s Surgical Pathology, 9th ed): “at least two thirds of the breast tissue (exclusive of adipose tissue) should be processed” National Consortium of Breast Centers, certain institutional protocols (e.g. UCLA): Entirely submit if specimen </= 5 cm in greatest dimension Northwestern: Entirely submit if </= 30 cassettes If too big to entirely submit, residents required to call attending or breast fellow to guide sampling

Arch Pathol Lab Med – Vol 133; January 2009. pp. 15-25.

CAP DCIS Protocol Clinical or radiologic lesion for which surgery was performed must be examined microscopically When known diagnosis of DCIS (eg, by prior core needle biopsy): highly recommended entire specimen be examined by using serial sequential sampling to… exclude the possibility of invasion completely evaluate the margins aid in determining extent If not possible, at least the entire region of the targeted lesion should be examined microscopically (note approx. % of specimen sampled) Sample, at a minimum, mammographically negative breast tissue flanking areas of calcification to be certain the entire extent of the lesion is represented If DCIS, LCIS or ADH is identified, all fibrous tissue should be examined All other gross lesions in the specimen must be sampled Margins should be evaluated -CAP: ink on DCIS for margin to be “positive” -NCCN: margins less than 0.1 cm inadequate -CAP: when margins positive Focal (eg, DCIS at the margin in a <0.1 cm area in 1 block) Minimal/moderate (between focal and extensive) Extensive (eg, DCIS at the margin in an area >/= 1.5 cm or in 5 or more low-power fields and/or in 8 or more blocks)

Excisions for DCIS Determinants of likelihood of local recurrence Nuclear grade Presence of Necrosis Distance from Margins Extent (size) of DCIS Predicting risk of local recurrence Probability of residual cancer in the breast Likelihood of close or involved margins Likelihood of finding, or missing, areas of invasion

Arch Pathol Lab Med – Vol 133; January 2009. pp. 15-25.

Extent of DCIS Often not recorded Difficult to measure Series of outside slide review: only 21% of cases reported the size of DCIS (Apple SK. Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue. Breast J. 2006;12:145-149) Most measurements were given as the largest dimension measured on a single slide Difficult to measure Mammographic extent often doesn’t correlate with microscopic extent No gross lesion Complexity of ductal system; Compressibility of breast tissue No standardized method for estimating the extent of DCIS

Methods for measuring extent of DCIS Single slide method: Underestimates extent in almost all cases when DCIS is greater than 1 cm Should only be used when DCIS is present in only one slide

Methods for measuring extent of DCIS Margins If DCIS involves two opposing margins, distance between margins can be used as extent of DCIS in the specimen Doesn’t happen often Arch Pathol Lab Med – Vol 133; January 2009. pp. 15-25.

Methods for measuring extent of DCIS Non-sequential sampling (block counting) Multiply #of blocks with DCIS by 0.4 cm Frequently underestimates extent Can overestimate, eg when DCIS is present in high volume (3-D) rather than predominantly linear distribution Arch Pathol Lab Med – Vol 133; January 2009. pp. 15-25.

Methods for measuring extent of DCIS Serial sequential sampling (mapping) method Preferred method by CAP, esp. if excision of known DCIS (largely because of substantial underestimation and overestimation by other methods) Routinely used in numerous breast centers (M.D. Anderson, Mayo, etc.) Arch Pathol Lab Med – Vol 133; January 2009. pp. 15-25.

Methods for measuring extent of DCIS Serial sequential sampling (mapping) method Entire specimen sectioned in sequence and block locations recorded Sliced specimen radiograph, block location marked on radiograph itself, correlates calcifications with block location Simple specimen diagram without sliced radiograph Calculate Average slice thickness = length of specimen/number of slices Size of DCIS = Number of consecutive slices involved X average slice thickness

Comparison of Methods for Measuring Extent of DCIS O’Malley (Mt. Sinai Hospital, Ontario, Canada) Compared (78 cases): Serial sequential sampling Calculation based on location of calcifications in specimen radiograph Non-sequential sampling (block method, using 0.3 cm) Single slide Mean number of blocks submitted per case: 26.7 (range, 8-66) Arch Pathol Lab Med – Vol 133; January 2009. pp. 31-37.

Comparison of Methods for Measuring Extent of DCIS O’Malley (Mt. Sinai Hospital, Ontario, Canada) Results All 3 alternative methods tended to underestimate DCIS Discrepancies more pronounced as size increased Difference as compared to SSS of 1 cm or less: 81%, 72%, 50% (Ca++, block, single slide) Difference of >2cm: 9%, 8%, 30% Arch Pathol Lab Med – Vol 133; January 2009. pp. 31-37.

- 18 slices Circles = Ca++ X = block with DCIS Sectioned mediolateral plane (specimen size 5.7 cm/18 slices = 0.3 avg. slice thickness) 0.3 cm x 8 slices = 2.4 cm Arch Pathol Lab Med – Vol 133; January 2009. pp. 31-37.

Comparison of Methods for Measuring Extent of DCIS Bose, et al (Cedars-Sinai Medical Center, LA) 98 cases Compared mapping method to block method (using 0.3 cm, 0.35 cm, 0.4 cm and 0.5 cm as the multiplier) Results Block method underestimated size in 71 cases (72%), by 4.5% to 81.3% (mean, 33%) Best concordance using 0.4 cm as the multiplier Arch Pathol Lab Med – Vol 133; January 2009. pp. 26-30.

Diagram extremely important in both selective and complete sampling Only way specimen can be reconstructed to accurately measure the size of DCIS

Excisions for MRI Detected Lesions When lesion detected only by MRI CAP recommends to entirely submit specimen for histologic examination No way of knowing if selective sampling encompasses the targeted lesion because radiographic specimen is of no value

Excisions For Mass Lesion Even less available in terms of published recommendations, but less debate Lester: Mass – Four to five cassettes of possible carcinomas, or 1 section per cm for other grossly evident masses In the absence of an identified mass, all fibrous breast tissue is submitted Margins – up to 12 perpendicular sections representing each of the six margins for oriented specimens suspicious for carcinoma or known to have carcinoma Normal tissue – At least one cassette of representative fibrous tissue if not present in the slides above

CAP Protocol For Invasive Breast Carcinoma Specimen sampling for specimens with invasive carcinoma has the following goals: Clinical or radiologic lesion for which surgery was performed must be examined microscopically If the lesion is a nonpalpable imaging finding, the specimen radiograph and/or additional radiologic studies may be necessary to identify the lesion When practical, the entire lesion, or the entire area with the imaging finding, should be submitted in a sequential fashion for histologic examination

CAP Protocol For Invasive Breast Carcinoma Continued: If specimen consists predominantly of DCIS with microinvasion, complete submission of the entire specimen, or at a minimum the entire grossly involved area, is recommended to identify additional areas of invasion and/or lymph-vascular invasion All other gross lesions in the specimen must be sampled Each designated margin must be evaluated for involvement by invasive carcinoma and DCIS

What I Do Always use a specimen diagram, regardless of reason for excision Always submit entirely if it will fit in 30 cassettes or less, regardless of reason for excision

What I Do When Not Feasible To Entirely Submit For mass lesion Submit at a minimum… Both ends entirely, perpendicularly sectioned At least 1 section per cm of mass At least one section from each tissue slice with mass and at least one section from flanking slices (In reality, when tumor 2 cm or less, I generally entirely submit all slices with tumor and the two flanking slices) At least one section from each remaining slice that has any fibrous tissue in it (include margin whenever close) Above sections to include at least 2 perpendicular sections of each margin

What I Do When Not Feasible To Entirely Submit For mammographic calcifications Submit at a minimum… Both ends entirely, perpendicularly sectioned Entirely submit all slices with lesion (slices indicated by grid, slices with biopsy site) Entirely submit two flanking slices All fibrous tissue if possible; at least one or more section of fibrous tissue per slice (each slice should be sampled) Above sections to include at least 2 perpendicular sections of each margin

Thank You!